Progressive Supranuclear Palsy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Remote Monitoring in Progressive Supranuclear Palsy (PSP)
Condition: Progressive Supranuclear Palsy Intervention: Sponsors: Massachusetts General Hospital; Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2021 Category: Research Source Type: clinical trials
A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy Intervention: Drug: UCB0107 (bepranemab) Sponsor: UCB Biopharma SRL Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2020 Category: Research Source Type: clinical trials
